Rivaroxaban (BAY 59‐7939) – an oral, direct Factor Xa inhibitor – has no clinically relevant interaction with naproxen [PDF]
Dagmar Kubitza +3 more
openalex +1 more source
Ingo Ahrens, Christoph Bode Heart Center, University of Freiburg, Department of Cardiology and Angiology I, Freiburg, Germany Abstract: The direct factor Xa inhibitor rivaroxaban was the first within the group of orally available direct factor Xa ...
Ahrens I, Bode C
doaj
In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban [PDF]
Grigoris Gerotziafas +4 more
openalex +1 more source
The 5 most frequently asked questions about factor Xa inhibitors. [PDF]
Wang TF, Carrier M.
europepmc +1 more source
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism. [PDF]
Li M +11 more
europepmc +1 more source
Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies [PDF]
Pancras C. Wong +7 more
openalex +1 more source
Platelet-rich fibrin ensures hemostasis after single-tooth removal under factor Xa inhibitors - a clinical prospective randomized split-mouth study. [PDF]
Kyyak S +4 more
europepmc +1 more source

